Sublingual immunotherapy for allergic Rhinoconjunctivitis, allergic asthma, and prevention of allergic diseases.
Calderón
Moisés A
MA
Allergy and Clinical Immunology, National Heart and Lung Institute, Imperial College London, London, UK.
Penagos
Martin
M
Durham
Stephen R
SR
D000286:Administration, Sublingual; D000485:Allergens / Q000276:immunology*; D001249:Asthma / Q000628:therapy*; D003231:Conjunctivitis / Q000628:therapy; D003888:Desensitization, Immunologic; D006801:Humans; D006967:Hypersensitivity / Q000276:immunology / Q000517:prevention & control / Q000628:therapy*; D012220:Rhinitis / Q000628:therapy
D000485:Allergens